Florence Pojer

Editer le profil

Responsable d'unité

florence.pojer@epfl.ch +41 21 693 19 76 https://www.epfl.ch/research/facilities/ptpsp/

Nationalité: Swiss-French

EPFL SV PTECH PTPSP
AI 2147 (Bâtiment AI)
Station 19
CH-1015 Lausanne

+41 21 693 19 76
+41 21 693 09 04
Local: AI 2147
EPFL > SV > PTECH > PTPSP

Web site: Site web: https://www.epfl.ch/research/facilities/ptpsp/

EPFL AVP-PGE EDMS-ENS
SV 2515 (Bâtiment SV)
Station 19
CH-1015 Lausanne

+41 21 693 19 76
Local: SV 2515
EPFL > VPA > VPA-AVP-PGE > AVP-PGE-EDOC > EDMS-ENS

Web site: Site web: https://go.epfl.ch/edms

EPFL VPRHO DSPS COSEC-SV
AI 2147 (Bâtiment AI)
Station 19
CH-1015 Lausanne

+41 21 693 19 76
Local: AI 2147
EPFL > VPO > VPO-SE > OHS > COSEC-SV

vCard
Données administratives

Domaines de compétences

Expert in Integrative Structural Biology, mainly X-ray Crystallography and SPR Cryo-EM
Expert in production and Purification of macromolecules, such as antibodies, membrane proteins and growth factors.

Mission

The mission of the facility is to connect researchers in Protein Sciences and Integrative Structural Biology. We advice, support and train scientists in production, purification and biophysical/structural characterisations of macromolecules, such as enzymes, antibodies or any kind of proteins you are interested in.

Travail en cours

Daily support of scientists in production and purification of proteins in various hosts
Daily support of scientists in X-ray crystallography, Bio-NMR and Single particle cryoEM pipelines to obtain atomic structures of their favourite proteins
Daily support of scientists in biophysical techniques and protein quality control

Parcours professionnel

Head of Protein Production and Structure Core Facility

School of Life Sciences

EPFL

2011-now

Staff scientist

Chair of Microbial Pathogenesis, Prof. Stewart Cole

EPFL

2007-2018

Post-doc

Structural Biology lab, Prof. Joseph Noel

The Salk Institute (La Jolla, USA)

2004-2007

Formation

PhD thesis

Antibiotic research

Tuebingen (Germany)

1999-2003

Pharm D

Pharmacy School

Besancon (France)

1992-1998

Publications

Publications Infoscience

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors

U. F. Roehrig; S. R. Majjigapu; P. Vogel; A. Reynaud; F. Pojer et al.

Journal Of Enzyme Inhibition And Medicinal Chemistry. 2022-12-31. DOI : 10.1080/14756366.2022.2089665.

Florence Pojer

Responsable d'unité

Domaines de compétences

Mission

Travail en cours

Parcours professionnel

Formation

Publications

Publications Infoscience

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

A highly potent antibody effective against SARS-CoV-2 variants of concern

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response

Palmitoylated acyl protein thioesterase APT2 deforms membranes to extract substrate acyl chains

Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies

Structural investigation of ACE2 dependent disassembly of the trimeric SARS-CoV-2 Spike glycoprotein

Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains

High resolution CryoEM structure of the ring-shaped virulence factor EspB from Mycobacterium tuberculosis

De novo development of proteolytically resistant therapeutic peptides for oral administration

Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms

Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase

Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies

A rheostat mechanism governs the bifurcation of carbon flux in mycobacteria

Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-beta-D-ribose 2 '-oxidase

Lansoprazole is an antituberculous prodrug targeting cytochrome bc1

Structure of EspB, a secreted substrate of the ESX-1 secretion system of Mycobacterium tuberculosis

2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1

Internalization and vacuolar targeting of the brassinosteroid hormone receptor BRI1 are regulated by ubiquitination

The Crystal Structures of Apo and cAMP-Bound GlxR from Corynebacterium glutamicum Reveal Structural and Dynamic Changes upon cAMP Binding in CRP/FNR Family Transcription Factors

Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides

The cysteine desulfurase IscS of Mycobacterium tuberculosis is involved in iron sulfur cluster biogenesis and oxidative stress defence

Functional Dissection of Intersubunit Interactions in the EspR Virulence Regulator of Mycobacterium tuberculosis

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Pyridomycin bridges the NADH- and substratebinding pockets of the enoyl reductase InhA

Peptide ligands stabilized by small molecules

Structure and Function of Essential Components of Contractile Injection Systems

Phenotypic Profiling of Mycobacterium tuberculosis EspA Point Mutants Reveals that Blockage of ESAT-6 and CFP-10 Secretion In Vitro Does Not Always Correlate with Attenuation of Virulence

Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence

Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs

Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

Characterization of Molecular Determinants of the Conformational Stability of Macrophage Migration Inhibitory Factor: Leucine 46 Hydrophobic Pocket

Virulence Regulator EspR of Mycobacterium tuberculosis Is a Nucleoid-Associated Protein

Directed evolution of the suicide protein O⁶-alkylguanine-DNA alkyltransferase for increased reactivity results in an alkylated protein with exceptional stability

Structure and function of the transketolase from Mycobacterium tuberculosis and comparison with the human enzyme

Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-

EspD Is Critical for the Virulence-Mediating ESX-1 Secretion System in Mycobacterium tuberculosis

Atypical DNA recognition mechanism used by the EspR virulence regulator of Mycobacterium tuberculosis

Towards anti-virulence drugs targeting ESX-1 mediated pathogenesis of Mycobacterium tuberculosis

Sigma Factor F does not Prevent Rifampin Inhibition of RNA Polymerase or Cause Rifampin Tolerance in Mycobacterium tuberculosis

A finite element model of the LHC dipole cold mass with hysteretic, non-linear behavior and single turn description

Enseignement & Phd

Open and Outreach sciences

Cours

Integrative structural biology for Life sciences

Recombinant protein expression in animal cells for applications in medicine and structural biology

Methods: from disease models to therapy

Methods: omics in biomedical research

Liste complète des adresses et fonctions